Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-01-26 00:00:00 ET · period of report 2024-01-26 · accession 0000950170-24-008063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-01-26 | 2024-01-26 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $25.00 | -100 | 169.0K | -0.1% | -$2,500 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | S | D | 100 | $25.00 | 168,996 | D | — | — | (F2) Includes 145,667 unvested RSUs. |